UNSPSC 85514531: Bypass left common iliac artery to left common iliac artery with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass left common iliac artery to left common iliac artery with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 041D4K7

UNSPSC 85514531, Bypass left common iliac artery to left common iliac artery with nonautologous tissue substitute, percutaneous endoscopic approach, is a Commodity code that shows no recent state and local procurement activity aligned with its medical procedure scope. The source provides six recent state and local contract opportunities tagged under this code, but none involve the specific surgical procedure named; instead, they address occupational medical surveillance, independent medical evaluations for disability retirement determinations, surgical benefit carve-out program management, pharmacy benefit management, temporary health professional staffing, and emergency medical services for youth in custody. These opportunities are unrelated to bypass surgery or vascular intervention, indicating a mismatch between the UNSPSC taxonomy assignment and the actual work being solicited.

The issuing bodies in the source include city retirement offices (City of Phoenix), municipalities (City of Long Beach), state transportation departments (Washington State Department of Transportation), county health systems (County of Santa Clara, Harris County), and county human resources divisions (Collier County). Because the code does not map to actual procurement under this commodity and the recent opportunities span diverse medical service categories across Arizona, California, Washington, Florida, and Texas, this code presents no actionable market signal for vendors in vascular surgery or related device and services supply chains.